India’s first mRNA vaccine by Gennova gets DCGI approval

Daily Current Affairs / India’s first mRNA vaccine by Gennova gets DCGI approval

Change Language English Hindi

Category : National Published on: July 01 2022

Share on facebook

India’s first indigenously developed mRNA vaccine against the COVID-19 gets the Emergency Use Authorization (EUA), to be sold under the brand name GEMCOVAC™-19 and will be rolled out soon.
The vaccine will be available for adults above 18 years of age.
It is a two-dose vaccine to be administered intramuscularly at 28 days apart.
GEMCOVAC-19™ is the very first mRNA vaccine developed in India and the only third mRNA vaccine to be approved for COVID-19 in the world.
It is developed by The Pune-based subsidiary of Emcure Pharmaceuticals Ltd, Gennova Biopharmaceuticals Ltd.

Sudarshan Venu appointed Chairman and MD of TVS Motor effective August 25, 2025.
Read More....
Flipkart gets RBI nod to lend directly to customers and sellers via NBFC licence.
Read More....
Sara Errani and Andrea Vavassori win French Open 2025 mixed doubles title.
Read More....
Census 2027 to include caste data, will be held in two phases across India.
Read More....
Khichan and Menar wetlands in Rajasthan designated as new Ramsar sites.
Read More....
MoSPI releases 'EnviStats India 2025' on World Environment Day.
Read More....
S Mahendra Dev appointed as new Chairman of Economic Advisory Council to PM.
Read More....
Kumar Mangalam Birla receives USISPF Global Leadership Award 2025.
Read More....
Central Bank of India buys stake in Future Generali worth ₹451 crore.
Read More....
Government launches ‘Ayush Nivesh Saarthi’ portal to boost investment in traditional medicine.
Read More....

India’s first mRNA vaccine by Gennova gets DCGI approval